Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer

This study has been completed.

Study NCT00016120 Information provided by National Cancer Institute (NCI)

First Received: May 6, 2001 Last Updated: December 13, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)

Publications:

Slovin S, Ragupathi G, Clarke T, et al.: Multivalency in a phase II prostate cancer (PC) vaccine trial: are more antigens better? [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-671, 2003.